SteinCares to Distribute Bio-Thera Solutions' Biosimilars in LATAM

Photo:Representative Image

Bio-Thera Solutions, a biopharmaceutical company focused on developing innovative therapies and biosimilars, has announced a new licensing agreement with SteinCares, Latin America's leading specialty healthcare company. The deal grants SteinCares exclusive rights to distribute and market two biosimilars in Brazil and the rest of the region.

Under the agreement, Bio-Thera will complete the development of each biosimilar and file for regulatory approval with the FDA and EMA, which will support regulatory filings in LATAM. Bio-Thera will also be responsible for the commercial supply of biosimilars from its manufacturing facilities in Guangzhou, China.

SteinCares will leverage its extensive experience and understanding of the Latin American healthcare system to develop an optimal go-to-market strategy and maximize regional product access. The partnership will utilize SteinCares' strong local presence and its sales and marketing capabilities.

Mitchell Waserstein, CEO of SteinCares, expressed his excitement about the partnership, stating, "Partnering with Bio-Thera represents a step forward in our mission to create healthcare opportunities for patients in Latin America. 

This alliance strengthens our position as regional leaders in biosimilars, making us the preferred partner for global biotech and pharmaceutical companies entering the Latin American market. We are committed to helping patients access safe, innovative, and affordable treatments while upholding the highest ethical standards."

Dr. Shengfeng Li, CEO of Bio-Thera, also commented on the partnership, saying, "Bio-Thera is pleased to partner with SteinCares to commercialize the two biosimilars in Brazil and LATAM. We look forward to bringing these important products to Central and South America patients in collaboration with SteinCares."

SteinCares has over 40 years of healthcare experience and is a leader in commercializing and distributing specialty healthcare products in Latin America, including innovative pharmaceuticals, biosimilars, and complex generics. The company's presence in more than 30 countries in Latin America and the Caribbean makes it a valuable bridge between global pharmaceutical companies and the region's healthcare providers.